CRO Partnerships with MERIT

Specialized expertise informs every aspect of our CRO partnerships.

Many full-service Contract Research Organizations have elected to integrate and use our solutions to manage the imaging and data management elements of their clinical studies. Through our relationships with our partner CROs, we are thoroughly familiar with the hurdles that you face and what is required to meet and exceed your customer’s expectations. This specialized expertise informs every facet of our relationship with you, making our partnerships more efficient and simpler.

BENEFITS TO PARTNERING WITH MERIT

Transparent communication with prompt access to in-house experts

Deep bench of experienced and tenured staff trained in industry sponsored clinical trials, with a dedicated team for every project

We are often able to provide competitive pricing and shortened timelines for our CRO partners through efficiences gained from decades of experience

Proven track record supporting FDA approval of numerous products

EXCELSIORTM, our cloud-based software solution, is designed for imaging studies and is FDA 510(K) cleared for ophthalmic indications as well as HIPAA, 21 CFR Part11, and GDPR compliant. EXCELSIOR enhances the efficiency and accuracy of your imaging data collection and interpretation

MERIT’s innovative respiratory software application, CompleClinical®, simplifies and streamlines the pulmonary clinical trial process, improving the efficiency and accuracy of data capture, management,
and grading of spirometry data

Personalized attention, scalable solutions, and reliable clinical trial endpoint services

Some companies tend to overpromise and underdeliver, which puts your study success at risk. If you’re looking for a clinical trial endpoint services provider that will value your partnership and make your study a priority, consider MERIT.

TELL US ABOUT
YOUR PROJECT

Connect with us to learn more about how our expertise and approach can support bringing your product to market on-time and on-budget. Your success is our priority.